Search
for
Sort by
Research 391–420 of 1000+
- Targets to treat androgen excess in polycystic ovary syndrome
- Alopecia areata masquerading as frontal fibrosing alopecia
- Is the metabolism of testosterone to 5α-dihydrotestosterone required for androgen action in the skin?
- Rat steroid 5α-reductase kinetic characteristics: Extreme pH-dependency of the type II isozyme in prostate and epididymis homogenates
- Hirsutism and virilization
- Androgenetic, Diffuse and Senescent Alopecia in Men: Practical Evaluation and Management
- Hyperandrogenism in Adolescent Girls
- Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- Obesity and female androgenic alopecia: A cause and an effect?
- Sex Hormones and Hair Loss in Men From the General Population of Northeastern Germany.
- Hyperadrenocorticism in Ferrets
- PLASMA TESTOSTERONE GLUCOSIDURONATE: A RELIABLE INDICATOR OF FEMALE HYPERANDROGENISM (IDIOPATHIC HIRSUTISM AND ANDROGENIC ALOPECIA)
- DHT and E2 synthesis-related proteins and receptors expression in male yak skin during different hair follicle stages
- New Criteria for the Clinical Diagnosis of Hyperandrogenism in Polycystic Ovarian Syndrome and the Risk of Overdiagnosis
- Insulin resistance and β-cell dysfunction and the relationship with cardio-metabolic disorders among women with polycystic ovary syndrome
- Cosmetic Surgery Considerations in the Female Patient
- Markers of peripheral androgen action in vivo and in vitro
- Clomiphene Citrate versus Letrozole for Ovulation Induction in PCOS: A Comparative Study
- RETIRED: Managing Menopause Chapter 8 Sexuality and Menopause
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- Maternal androgen excess inhibits fetal cardiomyocytes proliferation through RB-mediated cell cycle arrest and induces cardiac hypertrophy in adulthood
- Polyzystisches Ovar-Syndrom (PCOS)
- Cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia
- Gonadal Sex Steroids: Production, Action and Interactions in Mammals
- Urinary steroid metabolome shows adrenal, gonadal, and neuroactive steroid dysregulation in adolescents with depression
- Clinical Utility of GnRH Analogues in Female Androgen Excess: Highlighting Diagnostic and Therapeutic Applications
- Postmenopausal Ovarian Hyperthecosis Associated with Rapid Testosterone Excess
- Treatment of hyperandrogenism in polycystic ovary syndrome
- BRIDGING THE GAP IN ACNE MANAGEMENT: A NARRATIVE REVIEW OF CURRENT THERAPIES AND THE EMERGENCE OF CLASCOTERONE